Cancer Cell Detection Manufacturers, Suppliers & Companies
-
Created in 2006, it4ip S.A. is a private company based on technologies developed at the UCLouvain (Belgium) in the 80’s. it4ip is also the acronym of “Ion track Technology 4 Innovative Products“, reflecting the group of 4 people being at the origin ...
-
Manufacturerbased in Sunnyvale, CALIFORNIA (USA)
Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to ...
Olympia - Model PCa-Px - Prognostic Test Kit
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient ...
CONTACT SUPPLIER -
Manufacturerbased in La Jolla, CALIFORNIA (USA)
Avelas is a clinical-stage drug-device company pioneering the field of fluorescence imaging for real-time cancer detection. Avelas is focused on the development and commercialization of pegloprastide (also referred to as “AVB-620”), a novel ...
-
Laboratorybased in Cochin, INDIA
SciGenom is an ISO certified company, with a fully functional state-of-the-art molecular biology laboratory in Cochin. Its R&D lab is recognized by Department of Scientific & Industrial Research (DSIR), Ministry of Science & Technology, Government ...
SciGenom - Model Anti-CD133 - Anti CD133 Monoclonal Antibody
CD133 antigen, also known as prominin, is a trans-membrane glycoprotein. It is a stem cell marker frequently found on multi-potent progenitor cells and is considered to be a cancer stem ...
CONTACT SUPPLIER -
Manufacturerbased in Paris Cedex 06, FRANCE
We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...
Rarecells - Technology of Liquid Biopsy
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the ...
CONTACT SUPPLIER -
Manufacturerbased in Irvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
MdxHealth - Methylation-Specific PCR Technology (MSP)
MDxHealth’s technology platform is called methylation-specific PCR (MSP), which is a proprietary DNA-based technology that functions on standard commercial PCR equipment. MSP is extremely powerful and accurate with the ability to ...
CONTACT SUPPLIER -
Manufacturerbased in New York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
-
Technologybased in Phoenix, ARIZONA (USA)
VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...
Model LuCED Test - Lung Cell Evaluation Device
The LuCED test is a non-intrusive sputum sample that we collect from you and then analyze using our Cell-CT machine. From this sample, LuCED is designed to detect lung cancer early by ...
CONTACT SUPPLIER -
Technologybased in Carlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
-
Technologybased in Austin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
-
Manufacturerbased in Villejuif, FRANCE
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...
-
Manufacturerbased in Shijiazhuang, CHINA
Hebei Lingding Biotechnology Co., Ltd. is a professional business company,that include pharmaceutical raw materials, pharmaceutical intermediates,and other more than 1000 products of the enterprise, The registered capital is 3 million yuan, it is a ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you